Skip to content
  • Sunday, 26 July 2026
  • 2:50 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Weekly Gilead and Merck oral HIV regimen maintains suppression in two phase 3 trials
Laboratory Automation & Robotics

Weekly Gilead and Merck oral HIV regimen maintains suppression in two phase 3 trials

Lana Keisha Jul 21, 2026 0

Recent findings presented at the 26th International AIDS Conference have underscored a significant advancement in HIV treatment, with an investigational…

Read More
Neuroscience & Brain Research

UCSF Researchers Uncover Biological Circuit Linking Gut Immune Response to Brain Signaling and Appetite Suppression During Parasitic Infection

Rifan Muazin Mar 29, 2026 0

The phenomenon is a familiar one: the sudden and profound loss of appetite that accompanies a severe gastrointestinal illness. While…

Read More
Pharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.Study: Toxic Exposure in Pregnancy May Drive Disease Risk Across GenerationsAmid vaccine policy whiplash, here’s how a pediatrician talks to familiesArtificial Intelligence Transforms Clinical Data Management, But Industry Adoption Lags Behind
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ